Eli Lilly and Company
Brenipatide
Smoking
Countdown
236days
Phase 2 readout · ~ Feb 28, 2027 estimated
What's at stake
Phase 2 trial results for Brenipatide in Smoking are due ~ Feb 28, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT07223840: Phase 2 trial, sponsor Eli Lilly and Company, drug Brenipatide. Primary completion date 2027-02 (estimated).”